April 20, 2014 3:12 AM ET

Pharmaceuticals

Company Overview of Warner-Lambert Company LLC

Company Overview

Warner-Lambert Company LLC manufactures and markets pharmaceutical, consumer health care, and confectionery products. It offers pharmaceuticals drugs, over-the-counter health care products, shaving and pet care products, chewing gums, breath-mints, and cough/throat tablets. The company was founded in 1920 and is based in Morris Plains, New Jersey. Warner-Lambert Company LLC operates as a subsidiary of Pfizer Inc.

201 Tabor Road

Morris Plains, NJ 07950

United States

Founded in 1920

44,000 Employees

Phone:

973-385-2000

Fax:

201-540-3761

Key Executives for Warner-Lambert Company LLC

Senior Vice President
Age: 65
Senior Vice President and General Counsel
Age: 66
Senior Vice President of Public Affairs
Age: 71
Senior Vice President
Age: 73
Senior Vice President of Strategic Management Processes
Age: 71
Compensation as of Fiscal Year 2013.

Warner-Lambert Company LLC Key Developments

RICO Claim Against Pfizer Inc., Warner-Lambert Company LLC Alleges Fraudulent Off-Label Marketing May Proceed

The U.S. Supreme Court declined to review a First U.S. Circuit Court of Appeals' decision reversing summary judgment in favor of a pharmaceutical firm in a civil Racketeer Influenced and Corrupt Organizations Act action brought by a third-party payor arising from the defendant's alleged fraudulent off-label marketing campaign. A class of third-party payors alleged Pfizer Inc. and Warner Lambert Co. engaged in a fraudulent off-label marketing campaign that caused third-party payors to pay for Neurontin prescriptions that were ineffective for the off-label conditions at issue, and that the plaintiffs suffered injuries in paying for those prescriptions. A district court granted summary judgment in favor of the defendants after concluding the plaintiffs failed to raise a fact issue as to causation. The plaintiffs appealed. The First Circuit reversed the district court's judgment. The First Circuit held the plaintiffs presented adequate evidence that Pfizer fraudulently promoted Neurontin for off-label treatment of bipolar disorder, such conduct likely caused harm to the plaintiffs and that such harm would be the expected consequence of Pfizer's conduct. The First Circuit held the causal chain between Pfizer's conduct and the plaintiffs' injuries was sufficiently direct to survive a summary judgment motion. Under U.S. Supreme Court precedent, the plaintiffs were not required to demonstrate they directly relied on Pfizer's misrepresentations, but instead needed to show only some direct relation between the injury asserted and the injurious conduct alleged. Therefore, the First Circuit remanded the case for further proceedings.

Similar Private Companies By Industry

Company Name Region
Selexagen Therapeutics, Inc. United States
XF Enterprises, Inc. United States
CBA Pharma, Inc. United States
Karos Pharmaceuticals, Inc. United States
OmniActive Health Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Warner-Lambert Company LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.